How The Narrative Around Rigel Pharmaceuticals (RIGL) Is Shifting With Raised Guidance And Cash Flow
Rigel Pharmaceuticals just saw its fair value estimate nudged from US$51.20 to US$51.60, a small move that still reflects some meaningful shifts in the story behind the stock. The model now blends ...
Trump’s proposed 10% credit card APR cap is repricing issuers and networks. The market’s reaction is driven by political risk ...
Hoisington Investment Management Company identifies eight disinflationary forces set to persist into 2026. View the full ...
Two Canadian stocks look positioned for a 2026 “restart,” with real catalysts beyond January seasonality. The post 2 Canadian ...
A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, ...
In an internal email to employees, accessed by Moneycontrol, founder Gaurav Munjal outlined the shift as part of a wider cost ...
However, with the stock still showing substantial gains year-to-date, is this merely a healthy consolidation or the ...
Long Trade IdeaEnter your long position between £412.60 (the lower band of its horizontal support zone) and £420.70 (Friday's ...
The next stumbling block is legacy processes that assume humans are doing all the work. Banking processes were historically ...
The next generation of investors will need to be “AI-fluent,” in a similar fashion to how analysts had to learn how to use ...
A broader set of sectors will be represented when 35 more S&P 500 companies report earnings this week, including Netflix, ...
Understand the relationship between AI and work, and how artificial intelligence is reshaping various job functions today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results